AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
67.26
+0.69 (1.04%)
At close:
Mar 23, 2023, 4:00 PM
67.47
+0.21 (0.31%)
After-hours:
Mar 23, 2023, 4:59 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $208.48 billion as of March 23, 2023. Its market cap has increased by 9.73% in one year.
Market Cap
208.48B
Enterprise Value
233.02B
1-Year Change
9.73%
Ranking
Category
Stock Price
$67.26
Market Cap Chart
Since May 12, 1993, AstraZeneca plc's market cap has increased from $7.64B to $208.48B, an increase of 2,627.71%. That is a compound annual growth rate of 11.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 22, 2023 | 208.48B | 0.46% |
Mar 21, 2023 | 207.54B | 0.37% |
Mar 20, 2023 | 206.76B | 1.72% |
Mar 17, 2023 | 203.26B | -0.56% |
Mar 16, 2023 | 204.41B | 2.17% |
Mar 15, 2023 | 200.07B | -0.78% |
Mar 14, 2023 | 201.65B | -0.14% |
Mar 13, 2023 | 201.93B | 1.54% |
Mar 10, 2023 | 198.86B | 0.14% |
Mar 9, 2023 | 198.58B | -0.03% |
Mar 8, 2023 | 198.64B | -0.26% |
Mar 7, 2023 | 199.17B | -0.42% |
Mar 6, 2023 | 200.01B | -0.98% |
Mar 3, 2023 | 201.99B | 0.15% |
Mar 2, 2023 | 201.68B | -0.17% |
Mar 1, 2023 | 202.02B | 0.05% |
Feb 28, 2023 | 201.93B | -2.43% |
Feb 27, 2023 | 206.95B | 0.65% |
Feb 24, 2023 | 205.61B | -1.53% |
Feb 23, 2023 | 208.81B | -2.11% |
Feb 22, 2023 | 213.30B | -1.06% |
Feb 21, 2023 | 215.59B | 0.90% |
Feb 17, 2023 | 213.67B | 1.50% |
Feb 16, 2023 | 210.51B | -2.50% |
Feb 15, 2023 | 215.90B | -0.92% |
View and export this data all the way back to 1993.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Amgen Inc. | 122.70B |
Sanofi | 119.22B |
Gilead Sciences, Inc. | 96.41B |
Intuitive Surgical, Inc. | 83.29B |
Regeneron Pharmaceuticals, Inc. | 80.38B |
Vertex Pharmaceuticals Incorporated | 76.04B |
Moderna, Inc. | 57.96B |
Illumina, Inc. | 35.48B |
BioNTech SE | 31.46B |